in this phase ii trial , 105 eligible patients with no prior chemotherapy and advanced sarcoma received doxorubicin , ifosfamide , and dacarbazine ( dtic ) with mesna uroprotection ( maid ) .
C0013089
doxorubicin
C0338361
maid